Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of malaria in patients aged 18 years and older.

The QIAprep&amp Plasmodium Kit simplifies malaria research by enabling the detection of all five Plasmodium species in human samples. "Malaria research and surveillance remains critical in the ...

Malaria remains a persistent public health burden, with Plasmodium falciparum causing the most dangerous form of malaria and ...

(RTTNews) - QIAGEN N.V. (QGEN) has unveiled the QIAprep& Plasmodium Kit along with two companion assays to enhance efforts in malaria research and monitoring. This innovative solution streamlines ...

He said, “Most of the RTDs used for testing malaria in Nigeria ... of diagnostic kits. “It is important that we periodically determine the profile of the plasmodium parasite in Nigeria ...

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them in Africa QIAprep&amp Plasmodium Kit enables streamlined detection of ...

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them in Africa QIAprep&amp Plasmodium Kit enables streamlined detection of five ...

VENLO, Netherlands, April 01, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to ...